Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CE/BZA in Postmenopausal Prediabetic Women Veterans
NCT05073237Phase 2Withdrawn
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bazedoxifene in menopause, prediabetes, sponsored by VA Office of Research & Development. Planned start Apr 2024; status: withdrawn.
02
Drugs
bazedoxifene
03
Conditions
menopauseprediabetes
Beyond the preview
Go deeper on NCT05073237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073237.